HRT Financial LLC purchased a new position in shares of UnitedHealth Group (NYSE:UNH) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 6,479 shares of the healthcare conglomerate’s stock, valued at approximately $1,428,000. UnitedHealth Group makes up about 1.5% of HRT Financial LLC’s holdings, making the stock its 7th biggest position.
Other hedge funds also recently added to or reduced their stakes in the company. King Wealth Management Group LLC raised its holdings in shares of UnitedHealth Group by 5.5% in the 4th quarter. King Wealth Management Group LLC now owns 13,563 shares of the healthcare conglomerate’s stock worth $2,991,000 after purchasing an additional 712 shares in the last quarter. Smith Asset Management Group LP raised its holdings in shares of UnitedHealth Group by 21.3% in the 4th quarter. Smith Asset Management Group LP now owns 58,600 shares of the healthcare conglomerate’s stock worth $12,919,000 after purchasing an additional 10,300 shares in the last quarter. Cookson Peirce & Co. Inc. bought a new stake in shares of UnitedHealth Group in the 4th quarter worth approximately $243,000. Logan Capital Management Inc. raised its holdings in shares of UnitedHealth Group by 11.3% in the 4th quarter. Logan Capital Management Inc. now owns 27,829 shares of the healthcare conglomerate’s stock worth $6,135,000 after purchasing an additional 2,825 shares in the last quarter. Finally, Johnson Financial Group Inc. raised its holdings in shares of UnitedHealth Group by 2.8% in the 4th quarter. Johnson Financial Group Inc. now owns 19,995 shares of the healthcare conglomerate’s stock worth $4,408,000 after purchasing an additional 553 shares in the last quarter. Institutional investors own 86.80% of the company’s stock.
Shares of UNH opened at $221.90 on Thursday. UnitedHealth Group has a 52 week low of $164.60 and a 52 week high of $250.79. The company has a market cap of $215,527.55, a P/E ratio of 22.04, a P/E/G ratio of 1.30 and a beta of 0.77. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.58.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 20th. Investors of record on Friday, March 9th were given a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a yield of 1.35%. The ex-dividend date of this dividend was Thursday, March 8th. UnitedHealth Group’s payout ratio is presently 29.79%.
UNH has been the topic of a number of research reports. Goldman Sachs initiated coverage on shares of UnitedHealth Group in a report on Wednesday, January 3rd. They issued a “buy” rating and a $269.00 target price on the stock. Credit Suisse Group reissued a “buy” rating on shares of UnitedHealth Group in a research report on Wednesday, December 27th. Cantor Fitzgerald reissued a “buy” rating and issued a $235.00 target price on shares of UnitedHealth Group in a research report on Monday, December 25th. Deutsche Bank lifted their target price on shares of UnitedHealth Group to $260.00 and gave the stock a “buy” rating in a research report on Wednesday, January 17th. Finally, Citigroup lifted their target price on shares of UnitedHealth Group from $235.00 to $268.00 and gave the stock a “buy” rating in a research report on Wednesday, January 17th. Two analysts have rated the stock with a hold rating and twenty-six have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus target price of $244.06.
In other UnitedHealth Group news, insider Larry C. Renfro sold 22,184 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, March 15th. The shares were sold at an average price of $228.94, for a total value of $5,078,804.96. Following the completion of the sale, the insider now directly owns 173,229 shares in the company, valued at $39,659,047.26. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Richard T. Burke sold 10,000 shares of UnitedHealth Group stock in a transaction that occurred on Monday, March 19th. The shares were sold at an average price of $224.36, for a total transaction of $2,243,600.00. Following the completion of the sale, the director now owns 1,771,257 shares of the company’s stock, valued at $397,399,220.52. The disclosure for this sale can be found here. Insiders sold 77,015 shares of company stock valued at $17,879,199 over the last quarter. Corporate insiders own 0.89% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This piece of content was reported by Dakota Financial News and is the property of of Dakota Financial News. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of United States & international copyright legislation. The legal version of this piece of content can be read at https://dakotafinancialnews.com/2018/04/12/hrt-financial-llc-purchases-shares-of-6479-unitedhealth-group-unh.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.